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ABSTRACT 
Background: The proprotein convertase 1/3 (PC1/3), encoded by PCSK1, cleaves and hence 
activates several orexigenic and anorexigenic proproteins. Congenital inactivation of PCSK1 
leads to obesity in human but not in mice. However, a mouse model harboring the 
hypomorphic mutation N222D is obese. It is not clear why the mouse models differ in 
phenotype.  
Methods: Gene expression analysis was performed with pancreatic islets from 
Pcsk1
N222D/N222D
 mice. Subsequently, biosynthesis, maturation, degradation and activity was 
studied in islets, pituitary, hypothalamus and cell lines. Coimmunoprecipitation of PC1/3-
N222D and human PC1/3 variants associated with obesity with the ER chaperone BiP was 
studied in cell lines.  
Results: Gene expression analysis of islets of Pcsk1
N222D/N222D 
mice showed enrichment of 
genesets related to the proteasome and the unfolded protein response. Steady-state levels of 
PC1/3-N222D and in particular the carboxy-terminally processed form were strongly reduced 
in islets, pituitary and hypothalamus. However, impairment of substrate cleavage was tissue 
dependent. Proinsulin processing was drastically reduced, while processing of POMC to 
ACTH in pituitary was only mildly impaired. Growth hormone expression and IGF1 levels 
were normal, indicating near-normal processing of hypothalamic proGHRH. PC1/3-N222D 
binds to BiP and is rapidly degraded by the proteasome. Analysis of human PC1/3 obesity-
associated mutations showed increased binding to BiP and prolonged intracellular retention 
for all investigated mutations, in particular for PC1/3-T175M, PC1/3-G226R and PC1/3-
G593R.  
Conclusions: This study demonstrates that the hypomorphic mutation in Pcsk1
N222D
 mice has 
an effect on catalytic activity in pancreatic islets, pituitary and hypothalamus. Reduced 
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substrate processing activity in Pcsk1
N222D/N222D 
mice is due to enhanced degradation in 
addition to reduced catalytic activity of the mutant. PC1/3-N222D binds to BiP, suggesting 
impaired folding and reduced stability. Enhanced BiP binding is also observed in several 
human obesity-associated PC1/3 variants, suggesting a common mechanism. 
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INTRODUCTION 
The proprotein convertase subtilisin/kexin type 1 (PCSK1) and the leptin genes were the first 
genes discovered to cause monogenic obesity (1,2). PCSK1 encodes the proprotein convertase 
PC1/3 that belongs to a family of seven serine proteases which share high resemblance to 
yeast KEXIN and bacterial subtilisins. All PC members cleave proproteins carboxy-terminal 
of basic amino acid motifs (3,4). 
PC1/3 is highly expressed in neural and endocrine tissues such as the hypothalamus, pituitary 
and the pancreatic islets, were it often co-localizes with PC2 in dense-core granules. PC1/3 
activity is necessary for the activation of several prohormones and proneuropeptides. . After 
synthesis and signal peptide removal, the resulting zymogen proPC1/3 (95kDa) requires 
autocatalytic cleavage of the prodomain at two sites (5,6). The first cleavage is necessary for 
exit out the endoplasmic reticulum (ER). The second cleavage is predicted to occur in the 
Golgi and leads to the release of the prodomain, rendering the enzyme active against 
substrates in trans. Late in the secretory pathway PC1/3 can undergo carboxy-terminal 
cleavages at two possible positions which results in an intermediate (74kDa) or a smaller, less 
stable but more active form of PC1/3 (66kDa).  
Many PC1/3 substrates are involved in glucose homeostasis, feeding behavior and energy 
homeostasis. Rare and common polymorphisms in PCSK1 have been associated with obesity, 
increased body mass index, altered glucose homeostasis, proinsulin disorders, fat oxidation 
and postabsorptive resting energy expenditure  (7–14). Complete lack of PC1/3 causes a 
severe block in neuroendocrine proprotein processing, leading to a multi-hormonal disorder. 
In total 20 patients with congenital PC1/3 deficiency have been identified (1,6,14–19). In 
early childhood, patients become severely obese. It is generally assumed that blocked 
processing of anorexigenic substrates causes hyperphagia and hence obesity, as demonstrated 
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in an ad libitum test meal (15). Most patients also present with severe malabsorptive diarrhea 
and consequential metabolic acidosis (6,14,15). The patients develop a complex 
endocrinopathy marked by growth hormone deficiency, hypocortisolemia, hypothyroidism, 
hypogonadotropic hypogonadism and diabetes insipidus, albeit with large patient to patient 
variations.  
In 2002, the Pcsk1 knockout mouse model was reported not to be obese but growth retarded 
due to a block of proGHRH processing in the hypothalamus (20). The mouse model is marked 
by a combination of complete and partial block of processing of neuroendocrine substrates. In 
a forward genetic screen using N-ethyl-N-nitrosourea as mutagen, the N222D mutation in 
mouse PC1/3 was reported to cause obesity in a dominant manner when mice were fed a high 
fat diet (21). In vitro, human PC1/3-N222D, was reported to cause a 34-50% decrease in 
activity (21). This suggested that a reduction in PC1/3 activity of 25% or less in heterozygous 
N222D mice causes obesity, while loss of 100% activity in PC1/3 does not. A molecular 
explanation for this apparent paradox has not been found. Recently, eight novel heterozygous 
mutations in PCSK1 have been reported to predispose to obesity (13). It was shown that five 
of these mutations, as well as the mouse N222D mutation and the polygenic SNP rs6232 
coding for N221D, cluster around the Calcium 1 binding site (Ca-1) in PC1/3. This site is 
known to be important for structural stability of subtilisin, the prokaryote orthologue of PC1/3 
(22). In this study, we have investigated the pathogenesis of obesity in the PC1/3-N222D 
mouse model and whether this molecular mechanism also applies to common and rare human 
PCSK1 mutations. 
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Research Design and Methods 
Animal breeding 
The C57BL/6J-Pcsk1
N222D
/J mouse model, hereafter referred to as Pcsk1
N222D/N222D
, was 
obtained at Jackson Laboratories. PC1/3-null mice (20) (Pcsk1
KO/KO
) were obtained from Dr. 
Robert Day (Sherbrooke, Canada). The mice were housed in the specific pathogen free 
facility of the KU Leuven and all experiments were conducted with a priori approval by the 
local ethical committee (P072/2011). All experiments were conducted on 14 weeks old mice 
which had received four weeks high fat diet (HFD) (45% calories from fat) or normal fat diet 
(ND) (11% calories from fat). 
Tissue isolation 
Pancreatic islets were isolated for RNA isolation as previously described (23). For the 
collection of protein samples the pancreata were locally injected with Liberase TL (Roche 
Applied Science, Basel, Switzerland) as previously described (24). Pituitaries and 
hypothalami were dissected macroscopically and all tissues were snap-frozen in liquid 
nitrogen till later use. 
Site directed mutagenesis 
For in vitro experiments, the previously described human PCSK1 constructs were adapted 
(13). The hypermorphic mutation in this construct (25) was mutated back to wildtype using 
site directed mutagenesis. Similarly to the human constructs a FLAG-tag was inserted 
carboxy-terminal of the prodomain of mouse PC1/3 and the N222D mutation was created 
using QuickChange site directed mutagenesis kit (Stratagene, La Jolla, CA, USA). Constructs 
were verified by Sanger sequencing. For viral transduction the constructs were cloned into the 
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pLenti-GFP-PURO (26) eukaryotic expression vector where the GFP gene was replaced by 
either human or mouse PCSK1 constructs. 
Cell culture and viral transduction 
For virus production, HEK293T cells were triple transfected with 0.1µg Δ8.9, 0.9µg VSV-G 
and pLenti-empty, pLenti-Pcsk1 or pLenti-Pcsk1-N222D (for 10 cm²) using Xtreme gene 9 
transfection reagent. Insulinoma βTC3 cells were transduced with lentivirus and selected 
using 2µg/ml puromycin for two days. The activity measurement was conducted as described 
previously (12).  
Immunoblotting and immunoprecipitation 
Recombinant PC1/3 with Flag-tag was immunoprecipitated as described previously using the 
FlagM2 antibody (Sigma Aldrich, Saint Louis, MO, USA)(13). For intracellular PC1/3, cells 
were lysed in lysis buffer (150mM Tris-HCl pH 7.4, 50mM NaCl, 1% Triton-X-100, 1x 
Complete Mini Protease inhibitors (Roche Applied Science, Basel, Switzerland). 
Immunoprecipitated PC1/3 or other protein samples were separated by SDS-PAGE and 
Western blot was conducted with antibodies for FlagM2 (Sigma Aldrich, Saint Louis, MO, 
USA), BiP (CS 3177), IRE1alpha(CS 3294), eIF2alpha (CS 2103) (Cell signaling, Danvers, 
MA, USA), PC1/3 (1) and N-term. PC1/3 (kind gift from Dr. Iris Lindberg), insulin #3B7 
(kind gift from Dr. John Hutton, Denver, USA), P-IRE1alpha (NB100-2323), ATF6 (IMG-
273) (Novus biologicals, Littleton, CO, USA), P-eIF2alpha (27), ACTH (A1A12, kind gift 
from Dr. Anne White). 
Metabolic labeling 
Cells were metabolically labeled with 100µCi 
35
S methionine/cysteine (Easytag express 
protein labeling mixture, specific activity, 1,175 Ci/mmol, PerkinElmer; Waltham, MA, USA) 
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for 30 minutes and chased in RPMI1640 containing an excess (0.4mM) of unlabeled 
methionine and cysteine (both 0.4mM) for the indicated times. Cells were lysed in 1ml lysis 
buffer. PC1/3 was immunoprecipitated as described above and samples were run on SDS-
PAGE, followed by autoradiography. For inhibition of the proteasome and the lysosome the 
inhibitors were added during starvation, pulse and chase of the cells. MG132 was dissolved in 
DMSO (1000x), and used at a final concentration of 50µM. Leupeptin and chloroquine 
(Sigma Aldrich, Saint Louis, MO, USA) were added at a final concentration of 200µM and 
100µg/ml, respectively. 
RNA extraction and Microarray 
Total RNA from islets was isolated using Absolutely RNA microprep kit (Agilent, Santa 
Clara, CA, USA) according to the manufacturer’s protocol. RNA quantity and quality were 
assessed using a spectrophotometer (ND-1000; NanoDrop Technologies, (Wilmington, DE, 
USA) and a Bioanalyser (2100; Agilent, Santa Clara, CA, USA), respectively. Total RNA 
(100ng) of isolated islets was used to hybridize Mogene_1.0_ST array (Affymetrix, Santa 
Clara, CA, USA) according to the manufacturers protocol manual 4425209RevB as described 
previously (23). For RT-qPCR, RNA was isolated using the RNAxs kit (Machery-Nagel, 
Düren, Germany). cDNA was prepared from 250 or 500ng RNA using iScript cDNA 
synthesis kit (Bio-Rad, Hercules, CA, USA).  
Pathway analysis 
Linear expression values from the microarrays served as input in Gene Set Enrichment 
Analysis 2.013 (GSEA) (28). This tool identifies whether predefined genesets are statistically 
significantly different between two biological states. Enrichment analysis was carried out 
using the curated canonical pathways database present at Broad Institute. Enriched gene sets 
were clustered using Enrichment Map in Cytoscape 3.20 (29). The similarity coefficient 
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between gene sets was used as a proxy for spring-electric layout using AllegroLayout plugin. 
For analysis of enriched DNA binding motifs, the data was loaded in Multi experiment viewer 
(MeV, TM4) (30). Data was median/center normalized and analyzed with Significance 
analysis of Microarrays (SAM). The 100 genes containing the highest observed d-score were 
selected for iREGULON analysis (31). Enrichment score threshold was set at 3.0, ROC 
threshold for AUC at 0.03 and maximum false discovery rate on motif similarity at 0.001. 
RT-qPCR 
Real-time RT-qPCR was performed using iQ SYBR Green Supermix (Bio-Rad, Hercules, 
CA, USA). Forty cycles of annealing/extension for 1 min at 60°C were carried out with the 
MyiQ single color real-time PCR detection system (Bio-Rad, Hercules, CA, USA). Specific 
primers were designed using primer BLAST (NCBI). Primer efficiencies were tested using 
serial dilution of cDNA. Reference genes were selected from the microarray data and stability 
was assessed with Normfinder (32). Primer sequences and efficiencies are listed in 
supplementary Table 1. Gene expression was calculated as described by Hellemans et al (33). 
Metabolic measurements 
IGF-1 content was measured using the Quantikine ELISA Mouse/Rat IGF-I Immunoassay 
(R&D systems, Minneapolis, MN, USA) according to the manufacturer’s protocol. 
Measurement of total pancreas insulin content, was performed as described previously (24). 
Total immunoreactive insulin (proinsulin, insulin and processing intermediates) and specific 
mature insulin content was determined using the Rat High Range Insulin ELISA and the 
Mouse Ultrasensitive Insulin ELISA (Mercodia, Uppsala, Sweden), respectively. 
Intraperitoneal glucose (IGTT) and insulin (ITT) tolerance test were conducted as described 
previously (24).  
Immunohistochemistry 
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Tissues were isolated and fixed in 4% formaldehyde as previously described (24). Tissue 
slides of 5µM thickness were deparaffinized, hydrated and stained for KI67 (15580, Abcam, 
Cambridge, UK) to assess proliferation or for apoptotic cells using the TUNEL assay (In Situ 
Cell Death Detection Kit (Fluorescein) – Roche Applied Science, Basel, Switzerland) 
according to the manufacturer’s protocol.  
Statistics 
All data are represented as mean ± SEM unless indicated otherwise. Differences between 
groups were tested using unpaired two tailed T tests unless indicated otherwise. Sample size 
was determined, based upon the type of experiment. Differences in variance were tested with 
the Levene’s test.  
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Results 
Phenotypic analysis of Pcsk1
N222D/N222D
 shows a severe reduction in proinsulin processing  
The activity of PC1/3-N222D was assessed using an in vitro enzymatic assay (Figure 1A). 
Human PC1/3-N222D had residual activity of approximately 50%, conform previous reports 
(21,34). However, the activity of mouse PC1/3-N222D was reduced to background levels in 
the conditioned medium. Furthermore, little mouse PC1/3-N222D was secreted. These results 
indicate that the PC1/3 activity in Pcsk1
N222D/N222D
 mice is more severely impaired than 
assumed in the original publication where recombinant human PC1/3-N222D was used (21). 
Therefore, substrate processing was analyzed in the hypothalamus, pituitary and pancreatic 
islets of Pcsk1
WT/N222D 
and Pcsk1
N222D/N222D
 mice. Pcsk1
N222D/N222D 
mice appeared normal in 
size, had normal plasma IGF-1 concentrations and normal pituitary Gh expression (Figure 
1B-C). However, hypothalamic Ghrh expression was significantly increased (~40%) in 
Pcsk1
N222D/N222D
 mice (Fig. 1B). These results differ from those obtained with the Pcsk1 
knockout mice, which have decreased GH and IGF-1 levels and doubled proGHRH protein as 
a consequence of blocked proGHRH processing (20). In the pituitary, POMC was fully 
processed to 4.5-13 kDa ACTH, however, the ratio of the intermediate cleavage product 21-
23kDa proACTH and POMC was significantly increased in pituitaries of Pcsk1
N222D/N222D 
mice (Figure 1D). Total pancreatic immunoreactive insulin (including proinsulin and cleavage 
intermediates) after normal diet, was more than doubled (2.81-fold, P<0.05) in 
Pcsk1
N222D/N222D
 mice compared to wildtype littermates while specific insulin content was 
comparable across genotypes (Figure 1E). Western blot analysis on islets confirmed that 
proinsulin was highly increased in the islets from Pcsk1
N222D/N222D
 (Figure 1F).
 
Using non-
reducing conditions, a decrease in insulin and increase in insulin precursors is observed 
(Figure 1G) Metabolic labeling showed that proinsulin was not processed to detectable insulin 
levels in pancreatic islets from Pcsk1
N222D/N222D
 mice after a one hour chase (Figure 1H). 
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Glucose tolerance tests in Pcsk1
N222D/N222D 
mice was normal after a control diet, but impaired 
after four weeks on a HFD (Supplementary Figure 1A), indicating that proinsulin processing 
is severely perturbed when the metabolic load increases. Similarly, body weight was 
comparable in adult mice on ND, but significantly increased after HFD in Pcsk1
N222D/N222D
 in 
comparison to wildtype littermates
 
(Supplementary Figure 1B) Taken together, these results 
show that despite severely reduced activity of PC1/3-N222D in vitro, no evidence was found 
for physiologically relevant reductions in substrate processing in the GHRH/GH/IGF-1 axis 
and POMC to ACTH processing, despite increased precursor expression. Processing of 
proinsulin in pancreatic islets was more severely reduced, but only affected glucose 
homeostasis after HFD challenge. 
Gene expression analysis shows upregulation of unfolded protein response and 
proteasomal genesets 
The gene expression profile of pancreatic islets from mice fed a HFD was determined to 
investigate the impact of PC1/3-N222D (Figure 2A). Nine clusters of gene sets were 
identified that were significantly enriched in the pancreatic islets of the Pcsk1
N222D/N222D
 mice 
(False discovery rate (FDR)-q<0.01 and P<0.005), using gene set enrichment analysis 
(GSEA). The largest cluster consisted of gene sets linked to proteasomal protein degradation. 
One cluster contained gene sets for unfolded protein response (UPR) and XBP1s activation. 
Gene expression data was used to identify activated transcriptional pathways. The enrichment 
of DNA binding motifs in the 100 most differentially regulated genes (supplementary Table 
2) from the microarray was analyzed using iREGULON (31). The top 10 enriched DNA 
binding motifs are targets of ATF6, XBP1, CREB3, CREB3L1 or CREB3L2 and activate 
transcription of up to 21 genes from the input list (Table 1). CREB3 (OASIS), CREB3L1 
(LUMAN), CREB3L2 are bZIP transcription factors belonging to the OASIS family and 
share high homology with ATF6 (35). The observed enrichment of proteasomal and UPR 
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gene sets indicates that PC1/3-N222D might be degraded through ER-associated degradation 
(ERAD). This was investigated by Western blot analysis of PC1/3 in the hypothalamus, 
pituitary and pancreatic islets (Figure 2). In all these tissues a decrease in 66kDa PC1/3-
N222D could be observed, while the much less abundant 87 kDa form was less affected.  
PC1/3-N222D is rapidly degraded by the proteasome. 
The decreased immunoreactivity of 66kDa PC1/3 in Pcsk1
N222D/N222D
 tissues was further 
investigated in transiently transfected HEK293T and stably transduced insulinoma βTC3 cells 
(Figure 3A-D). In βTC3-cells, PC1/3-N222D did partly mature, but no carboxy-terminally 
processed form was present and a clear decrease was observed after eight hours of chase 
(Figure 3A). To investigate whether PC1/3-N222D is degraded by proteasomes or lysosomes, 
pulse chase experiments in the presence of either the proteasomal inhibitor MG132 or the 
lysosomal inhibitors choroquine and leupeptin (C/L), were performed (Figure 3B). 
Degradation of PC1/3-N222D in βTC3 cells was mostly prevented by proteasomal inhibition 
with little effect of the lysosomal inhibitors (Figure 3B). In HEK293T cells, mainly 
proPC1/3-N222D was detected while wildtype PC1/3 rapidly matured (Figure 3C). In 
addition, little intracellular immunoreactive PC1/3-N222D remained after four hours of chase, 
while considerable amounts of wildtype PC1/3 were still detectable even after eight hours. 
Taken together, the low amounts of PC1/3-N222D in the mouse model are most likely due to 
increased proteasomal degradation, as observed for recombinant PC1/3-N222D in cell lines. 
The glycosylation of mouse PC1/3-N222D was analyzed to identify whether PC1/3-N222D is 
able to exit the ER (supplementary figure 3). This shows that PC1/3 is not complex 
glycosylated in HEK293T cells and that glycan are endoglycosidase H sensitive indicating 
that most of PC1/3-N222D resides in the ER.  
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If PC1/3-N222D cannot fold stably, it is likely bound to the ER chaperone protein BiP, which 
binds transiently to unfolded proteins and more stably to misfolded proteins (36). To test this 
hypothesis, PC1/3 was immunoprecipitated from cell lysates of stably transduced βTC3 cells 
and co-immunoprecipitated BiP was detected by western blot (Figure 3D). Considerable 
amounts of BiP co-immunoprecipitated with PC1/3-N222D, similar to the previously reported 
null mutant PC1/3-G593R, which has previously been shown to be retained in the ER (1). 
Less, but clearly detectable amounts of BiP co-immunoprecipitated with wildtype PC1/3. 
These data suggest that PC1/3 requires BiP for folding and that PC1/3–N222D is indeed 
prone to misfolding and hence has a prolonged interaction with BiP.  
In order to determine whether PC1/3-N222D misfolding causes ER stress, the activation of 
the three canonical ER stress sensors: ATF6α, IRE1α, and eIf2α as a marker for PERK, was 
assessed. No difference in phosphorylation of the latter two was observed (Supplementary 
Figure 2). However, cleaved ATF6α was increased in the pancreatic islets of heterozygous 
mice, but not homozygous mice. No differences were observed in the pituitaries and 
hypothalami (Figure 3E-F).  
UPR activation was further investigated using RT-qPCR for downstream factors of XBP1 and 
ATF6α in the pancreatic islets (Figure 3G). No significant upregulation could be observed for 
Xbp1s, but a downstream target Erdj4, showed a significantly increased expression in both 
heterozygous and homozygous islets. Erdj4 encodes a co-chaperone for BiP which is 
correlated with ERAD (37). G2e3 and Serp1 were only upregulated in heterozygous mice. 
G2e3 is a E3 ubiqituine ligase and Serp1 encodes for an ER membrane protein involved in 
UPR. This observation was not due to loss of PC1/3 activity in the pancreatic islets as no 
differences were observed for pancreatic islets of Pcsk1
WT/KO
 mice.  
PC1/3-N222D expression causes reduced proliferation of pancreatic β cells 
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Cell cycle and cell cycle related processes were found to be different in the GSEA analysis. 
This suggests that PC1/3-N222D misfolding could have an effect on β cell proliferation and 
viability. Immunohistochemistry for the cell proliferation marker KI67 showed a severe 
decrease in β cell proliferation in Pcsk1WT/N222D and Pcsk1N22D/N222D mice when fed a high fat 
diet for four weeks (Figure 4 A/C). TUNEL staining showed no difference in the amount of 
apoptotic β cells (Figure 4 B/C). This suggests that on high fat diet β cells expressing PC1/3-
N222D are not able to compensate for the increased demand of insulin by increasing β cell 
proliferation. 
ER-retention of human PC1/3 mutants correlates with a higher binding to BiP  
The effect of human obesity-associated mutations in PC1/3 on folding was investigated by co-
immunoprecipitation of BiP. The eight previously reported heterozygous mutations (13), 
together with the common polymorphisms PC1/3-N221D, PC1/3-N221D-Q665E-S690T and 
the null mutant PC1/3-G593R were transiently expressed in HEK293T cells. PC1/3-T175M 
and PC1/3-G593R bound significantly increased amounts of BiP, while several other mutants 
showed moderately increased binding to BiP, albeit not significantly more than wildtype 
PC1/3 (Figure 5 A-B). Secondly, the effect of PC1/3 mutation on cell retention was 
investigated (Figure 5C). After one hour chase most wildtype PC1/3 was secreted from the 
cells, while all PC1/3 mutants were still detectable in the cell. Taken together, the majority of 
human variants showed either increased binding to BiP or delayed secretion or both.  
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Discussion  
In this study, we have investigated the effect of the N222D mutation on PC1/3 biology and 
substrate processing in a mouse model for HFD-induced obesity. We have shown that PC1/3-
N222D is prone to misfolding, binds to the ER chaperone BiP and is degraded by the 
proteasome. The amount of 66kDa carboxy-teminally processed PC1/3-N222D was decreased 
in the pancreatic islets, pituitary and hypothalamus. Processing was most severely affected in 
the pancreatic islets resulting in reduced amounts of insulin and a large amount of proinsulin. 
Processing of proGHRH in the hypothalamus and POMC to ACTH in the pituitary was not 
sufficiently affected to have physiological consequences. Several rare obesity-associated 
human PC1/3 mutants also showed increased BiP binding and prolonged ER retention, 
suggesting a common mechanism. 
Amino acid N222 in PC1/3 is predicted to be one of the side chain ligands of the calcium in 
the Ca-1 binding site (13). This site is conserved in both PCs and bacterial subtilisins and has 
been shown to be important for stability (22). The prolonged interaction with BiP and the 
rapid targeting for ERAD of PC1/3-N222D are consistent with impaired stability. It is striking 
that of the eight recently described obesity-associated mutants, five are located near (M125I, 
T175M, N180S, and Y181H) or directly ligated to (G226R) the Ca-1(13). Furthermore, one 
of the common polymorphisms linked to obesity (N221D) (34) is located adjacent to N222D 
and is therefore likely to have an effect on the stability of Ca-1 binding site as well. However, 
other mutations (T558A and S325N) not located near the Ca-1 binding site also showed 
increased intracellular retention, indicating that the Ca-1 binding site is not solely responsible 
for protein stability. 
Why mouse PC1/3 is more severely affected by the N222D mutation than human PC1/3 is 
unclear, but may be related to N-glycosylation. Mouse PC1/3 contains two functional N-
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glycan chains and human PC1/3 only one (13,38). Thermodynamic analysis has shown that 
N-glycosylation of proteins affects protein folding by destabilization of the unfolded state and 
correlates with the number of glycans (39). As a consequence, the two N-glycans in mouse 
PC1/3 might make the protein more sensitive to misfolding as a consequence of the N222D 
mutation. Recently Prabhu et al (40) showed that mouse PC1/3-N222D is degraded by the 
proteasome and is retained to the endoplasmic reticulum, which agrees with our observations. 
However, Prabhu et al also reported that the PC1/3-N222D has an extended intracellular half-
life in N2A cells, in contrast to our data in HEK293T and βTC-3 cells. We found that PC1/3-
N222D has a shorter half-life consistent with the observation that PC1/3-N222D is degraded. 
This discrepancy can most likely be explained by the fact that Prabhu et al used a construct 
where the carboxy-terminal cleavage site was mutated. 
Carboxy-terminal processing of PC1/3 results in a more active, but also less stable enzyme 
(41), and it is therefore not surprising that this 66kDa form is virtually absent in 
Pcsk1
N222D/N222D
 mice. As a consequence, proinsulin processing was severely delayed, 
including mildly decreased mature insulin levels. Glucose tolerance was normal when mice 
were fed a normal diet. Residual insulin activity from mature insulin and proinsulin is 
sufficient to maintain homeostasis. However, when fed a HFD mice became obese, glucose 
intolerant and had a decreased islet beta cell proliferation. Probably the reduced enzymatic 
activity and presence of PC1/3-N222D in the tissues result in an insufficient proinsulin 
processing leading to islet decompensation. Additionally, insulin producing β cells of 
Pcsk1
N222D/N222D
 mice may be more sensitive to ER stress (27). Previously Lloyd et al (21) 
showed that the islets of Pcsk1
N222D/N222D
 mice were hypertrophic, which was also noted by us 
during islet isolations. This suggests that during development islets become hypertrophic to 
cope with the absence of sufficient active insulin. Once the mice are given HFD, the β-cells 
decompensate and fail to proliferate in response to the increased metabolic demands. 
©    2016 Macmillan Publishers Limited. All rights reserved.
 The upregulation of ATF6α and increased expression of Erdj4, G2e3 and Serp1 in 
Pcsk1
WT/N222D
 pancreatic islets indicates a toxic effect of PC1/3-N222D when co-expressed 
with PC1/3-WT, which could lead to low grade ER stress in pancreatic islets of 
Pcsk1
WT/N222D
animals. Prabhu et al has shown that coexpression of PC1/3-N222D and PC1/3-
WT leads to a small decrease in secretion of PC1/3-WT (40). It is known for some proteins 
that oligomerization is a prerequisite for ER exit (42) and that PC1/3 is present in oligomers 
in the post ER compartments (43,44). It is therefore tempting to speculate that PC1/3-
N222D/PC1/3-WT heterodimers that are formed in the ER cannot be degraded as efficiently 
as PC1/3-N222D homodimers, perturb ER exit of PC1/3-WTand hence bind BiP for a 
prolonged period of time causing a more pronounced UPR. Such a model would also explain 
the dominant obesity phenotype in Pcsk1
WT/N222D 
animals when fed a high fat diet. Two other 
proprotein convertases, PC4 and PC7, have also been reported to bind BiP under normal 
conditions, indicating the need of BiP to assist in folding and prevent aggregation (45,46). In 
addition it has been reported that the expression and function of proprotein convertases and 
carboxypeptidases are highly dependent on ER homeostasis (47–49). 
 
Our in vivo data support the fact that PC1/3-N222D is still partly functional in the 
hypothalamus since the GHRH-GH-IGF-1 axis appeared not to be disturbed. This is in clear 
contrast to the PC1/3 null mice which displayed a dwarf phenotype as a consequence of 
unprocessed proGHRH (20). However, it has been reported that αMSH is nearly twofold 
decreased in hypothalami of Pcsk1
N222D/N222D
 mice, coinciding with hyperphagia (21). This 
could mean that decrease of PC1/3 activity is cell and/or substrate dependent. In addition, the 
activity of 66kDa PC1/3 might be required for proinsulin cleavage, whereas 87kDa PC1/3 
©    2016 Macmillan Publishers Limited. All rights reserved.
activity might be sufficient for other substrates explaining differential cleavage of PC1/3 
substrates in the Pcsk1
N222D/N222D 
mice. In the pituitary we found an increased amount of 
ACTH precursors and normal ACTH levels. In PC1/3 null patients normal ACTH and 
decreased cortisol levels were found in plasma as well, accompanied with increased POMC 
precursors (6,15). The expression of PC1/3-N222D in the pancreatic islets led to decreased 
insulin and accumulation of proinsulin, similar to PC1/3 null mice (20).  
In conclusion, our findings show that obesity in Pcsk1
N222D/N222D
 mice is caused by 
misfolding, binding to BiP and proteasomal degradation of PC1/3-N222D, leading to near-
complete loss of activity in the pancreatic islets and to a lesser extent in hypothalamus and 
pituitary. Molecular analysis of this mutant and the human obesity-associated PC1/3 
mutations suggest a common mechanism.   
©    2016 Macmillan Publishers Limited. All rights reserved.
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 FIGURE LEGENDS 
Figure 1. Mouse PC1/3-N222D does not show activity in vitro, but does not 
physiologically impair substrate processing Human and mouse PC1/3 constructs with or 
without the N222D mutation were transfected in HEK293T cells. A. Conditioned medium and 
cell lysates were used for Western blot and density of the bands was measured. The enzymatic 
activity was measured using a fluorogenic substrate. The PC1/3 activity, relative to protein 
levels, was normalized to human PC1/3-WT. The amount of PC1/3 in the medium and lysate 
were measured by densitometry of the Western blots. The ratio of secreted/cellular PC1/3 is 
also depicted. A representative Western blot for the expression of PC1/3 in HEK293T cells 
and conditioned medium is shown, n=5. B-C. Assessment of the GHRH-GH-IGF1 axis. B. 
Relative expression of Ghrh and Gh measured by RT-qPCR from RNA of mouse 
hypothalamic or pituitary respectively, n=3-5. C. Plasma IGF1 levels as measured by a 
specific ELISA, n=5-8. D. Western blot for ACTH and ACTH precursors from pituitary 
samples, n=5. Left, a schematic representation of PC1/3 and PC2 cleavage sites in POMC and 
the specific PC1/3 products which are formed in pituitary corticotrophs. Middle, a western 
blot for ACTH and ACTH precursors. Different panels originate from the same blot but were 
exposed for increasing time interval with decreasing Mw. Right, Quantification of band 
densities of different ACTH species. Non glycosylated (4.5kDa) and glycosylated 
(13kDa,(50)) ACTH band densities were summed and divided by POMC band densities. 
Similarly 21 and 23kDa bands were counted together as a measure for proACTH. The ratio of 
proACTH or ACTH over POMC is depicted. E. Proinsulin concentration is increased in islets 
of Langerhans (n=5-6). Left, total insulin levels measured by an ELISA kit which cross-reacts 
with proinsulin. The total amount of pancreatic insulin and proinsulin species are increased 
2.8 fold. Right, specific insulin levels measured by ELISA. F. Reducing Western blot for 
insulin in islets of Langerhans shows increased proinsulin species in Pcsk1
N222D/N222D 
islets. G. 
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Non-reducing Western blot of islets of Langerhans shows increased insulin precursors in 
Pcsk1
N222D/N222D 
islets. H. Proinsulin processing in pancreatic islets after 30 minutes of 
radiolabeling and one hour of chase. * P<0.05; data is represented as mean±SEM. 
Figure 2. Decreased 66kDa PC1/3 protein coincides with enrichment of proteasomal 
genesets in gene expression analysis. A. RNA from pancreatic islets from female mice fed a 
HFD for four weeks was used for microarray expression analysis. Linear expression values 
served as input in GSEA 2.013 (28). Enriched gene sets were clustered using Enrichment Map 
in Cytoscape 3.20 (29). Each node represents one gene set, the color of the node border 
represents FDR-q value with white color equals FDR-q=0.05 and black equals FDR-q=0. 
Overlap coefficient cut-off was set at 0.5, P-value cut-off was set at 0.005 and FDR-q cut-off 
was set at 0.05. For each cluster leading edge analysis was performed and most relevant gene 
set was used to name the clusters. B. Western blot for PC1/3 in pituitary, hypothalamic and 
pancreatic islets from female mice fed a HFD for four weeks. Arrowheads indicate specific 
bands. Similar results were observed for tissues of mice fed a normal fat diet. 
Figure 3. PC1/3-N222D binds BiP, is degraded by the proteasome and leads to increased 
ΔATF6α levels. Immunoprecipitation of mouse PC1/3 and PC1/3-N222D from βTC3 (A-B) 
cells or HEK293T (C) cells. Cells were metabolically labeled for 30 minutes and chased for 
the indicated times. B. Cells were treated with proteasomal (MG132) and lysosomal inhibitors 
(chloroquine and leupeptin [C/L]) as indicated. D. PC1/3, PC1/3-N222D and human PC1/3-
G593R were immunoprecipitated from βTC3 cells and co-immunoprecipitated BiP was 
detected by Western blot. * indicates an aspecific band. EV = empty vector. E. Western blot 
was performed with lysates from pancreatic islets, pituitary and hypothalamus tissues from 
mice fed a HFD for four weeks. F. Ratio of ∆ATF6α/ACTIN calculated from western blots, 
n=6 for islets, n=8 for pituitary and hypothalamus. A representative western blot is shown in 
panel E G. RT-qPCR analysis of target genes of Xbp1-spliced (Xbp1s) on cDNA from 
©    2016 Macmillan Publishers Limited. All rights reserved.
pancreatic islets of HFD fed mice. N=7-9. Data are depicted as mean ± SEM, * indicates 
P<0.05. Data from RT-qPCR was statistically tested with a one-sided T-test. 
Figure 4. Decreased proliferation of pancreatic β cells in  Pcsk1N222D/N222D mice. Paraffin 
embedded pancreata were used for double immunofluorescence staining. The amount of cells 
expressing insulin and/or the proliferation marker KI67 was counted and the ratio of 
proliferating cells calculated. Approximately 3000 β -cells were counted per mouse. Similarly 
pancreatic tissue was used to count the amount of apoptotic β cells in the pancreatic islets. 
Approximately 10000 cells were counted in a minimum of 50 islets per mouse. Each dot 
represents the percent proliferating/apoptotic β cells per mouse. Data are presented as median 
and individual data points. Statistical analyses were conducted with Mann-Whitney U test. * 
P<0.05, ** P<0.01, ***P<0.001. 
Figure 5. Human PC1/3 mutants bind BiP and are retained in the ER. Human PC1/3 
variants were expressed in HEK293T cells and PC1/3 was immunoprecipitated from the cell 
lysates. Proteins were separated by SDS-PAGE and Western blot analysis for BiP and PC1/3 
was performed. A. Representative image of a immunoprecipitation experiment. B. Ratio BiP/ 
PC1/3, n=7, median and interquartile range are depicted. Statistical analysis was conducted 
with Mann Whitney U test.†: P=0.06; **: P<0.01 C. HEK293T cells overexpressing PC1/3 
mutants were pulsed for 30 minutes and chased for indicated time points. PC1/3 was 
immunoprecipitated and separated by SDS-PAGE. A representative experiment is shown, 
n=4. 
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Table 1. Enrichment of DNA- binding motifs in increased expressed genes. 
# Rank Motif id AUC
* 
NES† Transcription factor 
1 
taipale-NNNGMCACGTCATC-XBP1-
DBD 0.11 10.18 Xbp1,Creb3,Creb3l1,Atf6,Atf6b,Creb3l2 
2 
taipale-NTGCCACGTCAYCN-CREB3-
full 0.11 9.91 Creb3,Xbp1,Creb3l1,Atf6,Atf6b,Creb3l2 
3 
taipale-NTGCCACGTCANCA-
CREB3L1-DBD 0.10 9.25 Creb3l1,Xbp1,Creb3,Atf6,Atf6b,Creb3l2 
4 
taipale-TGCCACGTCATCA-Creb3l2-
DBD 0.10 9.18 Taf9,Creb3l1,Creb3,Atf6,Atf6b,Creb3l2 
5 
taipale-NTGCCACGTCANCA-
CREB3L1-full 0.09 8.46 Creb3l1,Xbp1,Creb3,Atf6,Atf6b,Creb3l2 
6 transfac_public-M00356 0.09 7.95 Xbp1,Creb3,Creb3l1,Atf6,Atf6b,Creb3l2 
7 transfac_pro-M00936 0.08 6.98 E4f1 
8 transfac_pro-M01815 0.08 6.51  
9 transfac_public-M00483 0.07 6.30 Atf6,Creb3,Atf6b,Creb3l1 
10 CrebA_SANGER_5_FBgn0004396 0.07 6.24 Creb3l1,Creb3l2,Creb3,Atf6,Atf6b,Arnt2 
*
AUC: Area under the curve is used for motif detection for which the input genes are enriched 
at the top of the ranking. 
†
NES: Normalized enrichment score  
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